logo

For the Inventor, By the Inventor

Neshanic Station, NJ, United States of America

Te-Yen Chien

This inventor holds 5 USPTO granted patents. Top assignee: Agile Therapeutics, Inc.. Active years: 2006-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Te-Yen Chien. Retrieved from https://idiyas.com/inventor/te-yen-chien-id9q63v4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 40.0

Average Co-Inventor Count = 1.0

ph-index = 3

Forward Citations = 127(Granted Patents)


Location History:

  • Neshanic Station, NJ (US) (2006 - 2012)
  • Neschanic, NJ (US) (2014)

Company Filing History:

goldMedal5 out of 19 
 
Agile Therapeutics, Inc.
 patents

Years Active: 2006-2014

Loading Chart...
5 patents (USPTO):Explore Patents
1. 8883196 - Transdermal hormone delivery system: compositions and methods (2014-11-11),
2. 8221785 - Transdermal hormone delivery system: compositions and methods (2012-07-17),
3. 8221784 - Transdermal hormone delivery system: compositions and methods (2012-07-17),
4. 7384650 - Skin permeation enhancement composition for transdermal hormone delivery system (2008-06-10),
5. 7045145 - Transdermal contraceptive delivery system and process (2006-05-16),

Title: Te-Yen Chien: Innovator in Transdermal Hormone Delivery Systems

Introduction

Te-Yen Chien is a prominent inventor based in Neshanic Station, NJ (US). She has made significant contributions to the field of hormone delivery systems, particularly through her innovative work at Agile Therapeutics, Inc. With a total of 5 patents to her name, her inventions focus on improving the efficacy of hormone therapies.

Latest Patents

One of her latest patents is a transdermal hormone delivery system (THDS) designed for the control of fertility and the treatment of various diseases. This system utilizes a backing layer and an adhesive polymer matrix that contains effective amounts of progestin and estrogen hormones, specifically levonorgestrel. The THDS is engineered to enhance hormone delivery through skin permeation agents, allowing for effective daily doses from a small surface area of less than 20 square centimeters. The patent also outlines methods for fertility control and hormone replacement therapy using this advanced delivery system.

Career Highlights

Te-Yen Chien has established herself as a leader in the field of hormone delivery technology. Her work at Agile Therapeutics, Inc. has been pivotal in developing innovative solutions that address critical healthcare needs. Her patents reflect her commitment to enhancing patient care through effective hormone therapies.

Collaborations

Due to space limitations, the details of her collaborations will not be included.

Conclusion

Te-Yen Chien's contributions to transdermal hormone delivery systems exemplify her dedication to innovation in healthcare. Her work continues to impact the field positively, providing new solutions for hormone therapy and fertility control.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…